NCT06644963View on ClinicalTrials.gov

IMPELLA, Complications and Tolerance

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 1, 2010

Primary Completion Date

January 1, 2023

Study Completion Date

January 30, 2025

Conditions
Cardiogenic Shock
Interventions
DEVICE

Impella (5, 5.5 or CP)

Impella (5, 5.5 or CP) as an isolated circulatory support or combined with others Temporary Mechanical Circulatory Support

Trial Locations (1)

34295

RECRUITING

Montpellier university hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT06644963 - IMPELLA, Complications and Tolerance | Biotech Hunter | Biotech Hunter